RSVYX
Price
$26.54
Change
+$0.23 (+0.87%)
Updated
Jul 17 closing price
Net Assets
258.84M
VMVIX
Price
$65.67
Change
+$0.51 (+0.78%)
Updated
Jul 17 closing price
Net Assets
30.57B
Interact to see
Advertisement

RSVYX vs VMVIX

Header iconRSVYX vs VMVIX Comparison
Open Charts RSVYX vs VMVIXBanner chart's image
Victory RS Value Y
Price$26.54
Change+$0.23 (+0.87%)
VolumeN/A
Net Assets258.84M
Vanguard Mid-Cap Value Index Investor
Price$65.67
Change+$0.51 (+0.78%)
VolumeN/A
Net Assets30.57B
RSVYX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSVYX vs. VMVIX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSVYX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. RSVYX (259M). VMVIX pays higher dividends than RSVYX: VMVIX (2.14) vs RSVYX (0.56). RSVYX was incepted earlier than VMVIX: RSVYX (18 years) vs VMVIX (19 years). RSVYX (1.07) is less costly to investors than VMVIX (0.19). RSVYX is a more actively managed with annual turnover of: 39.00 vs. VMVIX (19.00). VMVIX has a lower initial minimum investment than RSVYX: VMVIX (3000) vs RSVYX (1000000). VMVIX annual gain was more profitable for investors over the last year : 4.95 vs. RSVYX (-5.20). VMVIX return over 5 years is better than : 67.64 vs. RSVYX (31.06).
RSVYXVMVIXRSVYX / VMVIX
Total Expense Ratio1.060.19558%
Annual Report Gross Expense Ratio1.070.19563%
Fund Existence18 years19 years-
Gain YTD1.1152.38047%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets259M30.6B1%
Annual Yield % from dividends0.562.1426%
Returns for 1 year-5.204.95-105%
Returns for 3 years8.7327.9331%
Returns for 5 years31.0667.6446%
Returns for 10 years-18.5185.72-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVLA31.232.81
+9.89%
Palvella Therapeutics Inc
TDACU10.43N/A
N/A
Translational Development Acquisition Corp
ALSN88.92-0.13
-0.15%
Allison Transmission Holdings
EXPI10.19-0.12
-1.16%
eXp World Holdings
NVNI0.34-0.01
-4.12%
Nvni Group Limited